Even though the SS is really not what I like, it is still a runner when the patents prove itself and now that the Trump administration is fast-tracking many FDA trials.
I'm in and believe this issue will go to a target of .001+
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.